Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

The Houthi rebels have detained two additional United Nations staff members and raided the homes of several others in Yemen ...

People, I think, have started looking outside the box when it comes to health care. And they’re turning more to wellness and ...

CHICAGO -- A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST ...

Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader ...

Researchers at Virginia Polytechnic Institute and State University took 20 people living with obesity (half on GLP-1s like ...

The approval was based on the SOUL trial, which evaluated oral semaglutide in adults 50 years and older with T2DM and ...

Incessant and debilitating thoughts about food seem to be a common experience for people with obesity. Telehealth giant Ro ...

Using semaglutide or tirzepatide for less than 2 years can cost as much as a Roux-en-Y gastric bypass — a one-time procedure ...

A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.

Patients with various combinations of CKM comorbidities who receive GLP-1RAs have decreased risk for HF hospitalization and CV death.

GLP-1 patches for weight loss have made the scene—but a leading MD warns you they aren't the same as the more familiar ...